Continuous CSF drainage in AD
- 15 July 2008
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 71 (3), 202-209
- https://doi.org/10.1212/01.wnl.0000316197.04157.6f
Abstract
Background: Alzheimer disease (AD) has been associated with abnormal cerebral clearance of macromolecules, such as amyloid and microtubule-associated-protein tau (MAP-τ). We hypothesized that improving clearance of macromolecules from the CNS might slow the progression of dementia.Keywords
This publication has 30 references indexed in Scilit:
- Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse ModelScience, 2007
- Human amyloid-β synthesis and clearance rates as measured in cerebrospinal fluid in vivoNature Medicine, 2006
- Neurovascular mechanisms of Alzheimer's neurodegenerationTrends in Neurosciences, 2005
- RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brainNature Medicine, 2003
- Downregulation of cerebrospinal fluid production in patients with chronic hydrocephalusJournal of Neurosurgery, 2002
- Clearance of Alzheimer’s amyloid-β1-40 peptide from brain by LDL receptor–related protein-1 at the blood-brain barrierJCI Insight, 2000
- Toward a Comprehensive Theory for Alzheimer's Disease. Hypothesis: Alzheimer's Disease Is Caused by the Cerebral Accumulation and Cytotoxicity of Amyloid β‐ProteinAnnals of the New York Academy of Sciences, 2000
- Longitudinal study of cerebrospinal fluid levels of tau, Aβ1–40, and Aβ1–42(43) in Alzheimer's disease: A study in JapanAnnals of Neurology, 1998
- Shunt fluid examination: risks and benefits in the evaluation of shunt malfunction and infectionJournal of Neurosurgery, 1984
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984